pharma · Lymphoma · Gastrointestinal Stromal Tumors · COGT
Cogent Biosciences
Cogent Biosciences trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.
275 Wyman Street, 3rd Floor, Waltham, Massachusetts 02451, US HQ
2014 Founded
283 Employees
Public company Type
COGT · NYSE Ticker
Company details
- Status
- Public
- HQ
- 275 Wyman Street, 3rd Floor, Waltham, Massachusetts 02451, US
- Founded
- 2014
- Employees
- 283
- Programs
- 13
- Drugs
- 8
- Patents
- 10
Cogent Biosciences clinical trials
Registry index of 13 ClinicalTrials.gov studies linked to Cogent Biosciences programs — each row shows trial ID, program name, phase, status, and indication.
Cogent Biosciences trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Cogent Biosciences.
-
CGT9486 plus sunitinib — Phase 3
Clinical update -
Bezuclastinib in combination with sunitinib — Phase 2
Clinical update -
ACTR T Cell Product — Phase 1
Clinical update -
CGT9486 — Phase 2
Clinical update -
Bezuclastinib Tablets (Formulation A) — Phase 2
Clinical update -
CGT9486, CGT9486 — Phase 2
Clinical update -
CGT4859 — Phase 2
Clinical update -
bezuclastinib — Phase 2
Clinical update